- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Visiplex sales power AFP revenue growth
AFP Imaging's fiscal 1996 financial results (end-June) got a strongboost from sales of electronic imaging components developed byVisiplex Instruments, which AFP acquired in 1995 (SCAN 8/16/95).AFP, of Elmsford, NY, said annual sales increased $10
AFP Imaging's fiscal 1996 financial results (end-June) got a strongboost from sales of electronic imaging components developed byVisiplex Instruments, which AFP acquired in 1995 (SCAN 8/16/95).AFP, of Elmsford, NY, said annual sales increased $10 million,although net income dropped.
For the year, AFP had revenues of $36.5 million, compared with$26.6 million in fiscal 1995. Net income stood at $701,000, comparedwith $924,000 in 1995. For the fourth quarter, AFP posted revenuesof $10.7 million and net income of $515,000, compared with salesof $6.7 million and net income of $470,000 in the fourth quarterof 1995.
AFP said Visiplex's product line has been integrated into AFP'smanufacturing and distribution process, and will provide a basefor AFP's expansion into digital imaging. On Sept. 12, AFP receiveda contract from an unnamed OEM customer for $900,000 in Visiplexproducts.
In addition, AFP last month launched a new line of Brightviewmonitors, which AFP claims has above-average brightness and resolution.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
